_id

691050e5ccc777a4e85d5429

Ticker

CMND

Name

Clearmind Medicine Inc. Common Shares

Exchange

NASDAQ

Address

1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.clearmindmedicine.com

Description

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.

Last Close

2.972

Volume

4099828

Current Price

2.72

Change

-8.479138627187071

Last Updated

2025-11-29T11:37:06.007Z

Image

data:image/webp;base64,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

Ipo Date

2021-08-16T00:00:00.000Z

Market Cap

5129786

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8558461538461538

Sentiment Sources

13

Current Quarter

2025-07-31

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

1407764

Operating Income

-1407764

Interest Expense

9192

Pretax Income

-1305334

Net Income

-1313592

Eps

-0.24418745367780778

Dividends Per Share

-

Shares Outstanding

33181024

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

79029

Cash

3495338

Short Term Investments

1084

Receivables

-

Inventories

-

Total Current Assets

3822093

Property Plant Equipment

26652

Total Assets

3969546

Payables

646919

Short Term Debt

-

Long Term Debt

-

Total Liabilities

2903878

Equity

1065668

Depreciation

12523

Change In Working Capital

208437

Cash From Operations

-1084838

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-10812

Net Change In Cash

-977182

PE

-

PB

0.3750628397399565

ROE

-123.2646565346806

ROA

-33.09174399288987

FCF

-1084838

Fcf Percent

-

Piotroski FScore

1

Health Score

28

Deep Value Investing Score

4.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

0.5

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

3.5

Quality Investing Score

1

Value Investing Score

5

Quarters > 0 > quarter

2025-07-31

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

1407764

Quarters > 0 > income Statement > operating Income

-1407764

Quarters > 0 > income Statement > interest Expense

9192

Quarters > 0 > income Statement > pretax Income

-1305334

Quarters > 0 > income Statement > net Income

-1313592

Quarters > 0 > income Statement > eps

-0.24418745367780778

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

5379441

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

79029

Quarters > 0 > balance Sheet > cash

3495338

Quarters > 0 > balance Sheet > short Term Investments

1084

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

3822093

Quarters > 0 > balance Sheet > property Plant Equipment

26652

Quarters > 0 > balance Sheet > total Assets

3969546

Quarters > 0 > balance Sheet > payables

646919

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

2903878

Quarters > 0 > balance Sheet > equity

1065668

Quarters > 0 > cash Flow > net Income

-1313592

Quarters > 0 > cash Flow > depreciation

12523

Quarters > 0 > cash Flow > change In Working Capital

208437

Quarters > 0 > cash Flow > cash From Operations

-1084838

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-10812

Quarters > 0 > cash Flow > net Change In Cash

-977182

Quarters > 0 > ratios > PE

-0.24418745367780778

Quarters > 0 > ratios > PB

0.3750628397399565

Quarters > 0 > ratios > ROE

-123.2646565346806

Quarters > 0 > ratios > ROA

-33.09174399288987

Quarters > 0 > ratios > FCF

-1084838

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

28

Quarters > 1 > quarter

2025-04-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

11970

Quarters > 1 > income Statement > gross Profit

-11970

Quarters > 1 > income Statement > operating Expenses

1306981

Quarters > 1 > income Statement > operating Income

-1306981

Quarters > 1 > income Statement > interest Expense

7868

Quarters > 1 > income Statement > pretax Income

-763270

Quarters > 1 > income Statement > net Income

-783928

Quarters > 1 > income Statement > eps

-0.15567569456800792

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

5035648

Quarters > 1 > income Statement > income Tax Expense

20658

Quarters > 1 > income Statement > EBITDA

-1295011

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

543711

Quarters > 1 > balance Sheet > cash

4472520

Quarters > 1 > balance Sheet > short Term Investments

177640

Quarters > 1 > balance Sheet > receivables

181321

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

5022737

Quarters > 1 > balance Sheet > property Plant Equipment

34137

Quarters > 1 > balance Sheet > total Assets

5180456

Quarters > 1 > balance Sheet > payables

475490

Quarters > 1 > balance Sheet > short Term Debt

71964

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

2878986

Quarters > 1 > balance Sheet > equity

2301470

Quarters > 1 > cash Flow > net Income

-783928

Quarters > 1 > cash Flow > depreciation

11970

Quarters > 1 > cash Flow > change In Working Capital

-69903

Quarters > 1 > cash Flow > cash From Operations

-1098398

Quarters > 1 > cash Flow > capital Expenditures

4.04

Quarters > 1 > cash Flow > cash From Investing

-200000

Quarters > 1 > cash Flow > cash From Financing

-10298

Quarters > 1 > cash Flow > net Change In Cash

-1308676

Quarters > 1 > ratios > PE

-0.15567569456800792

Quarters > 1 > ratios > PB

0.16256942145672115

Quarters > 1 > ratios > ROE

-34.06205599030185

Quarters > 1 > ratios > ROA

-15.132413053985982

Quarters > 1 > ratios > FCF

-1098402.04

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-01-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

12038

Quarters > 2 > income Statement > gross Profit

-12038

Quarters > 2 > income Statement > operating Expenses

1484136

Quarters > 2 > income Statement > operating Income

-1496173

Quarters > 2 > income Statement > interest Expense

8715

Quarters > 2 > income Statement > pretax Income

-1032286

Quarters > 2 > income Statement > net Income

-1071621

Quarters > 2 > income Statement > eps

-0.2387473894478217

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

4488514

Quarters > 2 > income Statement > income Tax Expense

39335

Quarters > 2 > income Statement > EBITDA

-1011533

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

463887

Quarters > 2 > balance Sheet > cash

5781196

Quarters > 2 > balance Sheet > short Term Investments

134723

Quarters > 2 > balance Sheet > receivables

209934

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

6414931

Quarters > 2 > balance Sheet > property Plant Equipment

44176

Quarters > 2 > balance Sheet > total Assets

6584957

Quarters > 2 > balance Sheet > payables

654187

Quarters > 2 > balance Sheet > short Term Debt

78188

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

3731281

Quarters > 2 > balance Sheet > equity

2853676

Quarters > 2 > cash Flow > net Income

-1071621

Quarters > 2 > cash Flow > depreciation

12038

Quarters > 2 > cash Flow > change In Working Capital

-188404

Quarters > 2 > cash Flow > cash From Operations

-1265435

Quarters > 2 > cash Flow > capital Expenditures

5

Quarters > 2 > cash Flow > cash From Investing

69462

Quarters > 2 > cash Flow > cash From Financing

404812

Quarters > 2 > cash Flow > net Change In Cash

-792617

Quarters > 2 > ratios > PE

-0.2387473894478217

Quarters > 2 > ratios > PB

0.11686561130275476

Quarters > 2 > ratios > ROE

-37.55230096198727

Quarters > 2 > ratios > ROA

-16.27377369358676

Quarters > 2 > ratios > FCF

-1265440

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-10-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

11512

Quarters > 3 > income Statement > gross Profit

-11512

Quarters > 3 > income Statement > operating Expenses

1574669

Quarters > 3 > income Statement > operating Income

-1586181

Quarters > 3 > income Statement > interest Expense

36160

Quarters > 3 > income Statement > pretax Income

-787624

Quarters > 3 > income Statement > net Income

-884744

Quarters > 3 > income Statement > eps

-0.2074338610320863

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

4265186

Quarters > 3 > income Statement > income Tax Expense

97120

Quarters > 3 > income Statement > EBITDA

-1179888

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

798557

Quarters > 3 > balance Sheet > cash

6573813

Quarters > 3 > balance Sheet > short Term Investments

289388

Quarters > 3 > balance Sheet > receivables

180877

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

7088239

Quarters > 3 > balance Sheet > property Plant Equipment

51663

Quarters > 3 > balance Sheet > total Assets

7255414

Quarters > 3 > balance Sheet > payables

526056

Quarters > 3 > balance Sheet > short Term Debt

36725

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

4147862

Quarters > 3 > balance Sheet > equity

3107552

Quarters > 3 > cash Flow > net Income

-884744

Quarters > 3 > cash Flow > depreciation

11512

Quarters > 3 > cash Flow > change In Working Capital

271992

Quarters > 3 > cash Flow > cash From Operations

-1077145

Quarters > 3 > cash Flow > capital Expenditures

4.71

Quarters > 3 > cash Flow > cash From Investing

-350400

Quarters > 3 > cash Flow > cash From Financing

323205

Quarters > 3 > cash Flow > net Change In Cash

-1105835

Quarters > 3 > ratios > PE

-0.2074338610320863

Quarters > 3 > ratios > PB

0.10197844470502827

Quarters > 3 > ratios > ROE

-28.47077056152238

Quarters > 3 > ratios > ROA

-12.194259348949625

Quarters > 3 > ratios > FCF

-1077149.71

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.24418745367780778

Valuation > metrics > PB

0.3750628397399565

Valuation > final Score

70

Valuation > verdict

62.5% Undervalued

Profitability > metrics > ROE

-123.2646565346806

Profitability > metrics > ROA

-34.36839448961603

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

2.7249368471231192

Risk > metrics > Interest Coverage

-153.151000870322

Risk > final Score

-595

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.90814769700689

Liquidity > metrics > Quick Ratio

5.90814769700689

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-634

Prev Risks > 1

-657

Prev Risks > 2

-145

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T13:16:08.595Z